The Flexibility Papers, No. 1: First Principles for a Rare Disease Framework

Yesterday, FDA and the Reagan-Udall Foundation for the FDA convened a public meeting to kick off stakeholder engagement on FDA’s new Rare Disease Framework Initiative.